PMA device
Propel Mini Sinus Implant
Intersect Ent. · Drug-Eluting Sinus Stent (OWO, Class III) · First FDA decision Sep 21, 2012, newest Mar 23, 2016Chronic sinusitis
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
PMA pathway
Device trials
3
Naming "Propel Mini"
MAUDE reports
9
Brand "Propel Mini", since 2015
PubMed studies
6
Mentioning "Propel Mini"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Propel Mini Sinus Implant
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
- PROPEL MINI SINUS IMPLANTPMA supplement
P100044-S018 · Decided Mar 23, 2016 · 180 days after receipt · Panel Track
Device type: Drug-eluting sinus stent (OWO) · Otolaryngology (ENT)
- PROPEL MINI SINUS IMPLANTSPMA supplement
P100044-S006 · Decided Jun 10, 2013 · 166 days after receipt · Normal 180 Day Track No User Fee
Device type: Drug-eluting sinus stent (OWO) · Otolaryngology (ENT)
- PROPEL MINI SINUS IMPLANTPMA supplement
P100044-S001 · Decided Sep 21, 2012 · 193 days after receipt · Normal 180 Day Track
Device type: Drug-eluting sinus stent (OWO) · Otolaryngology (ENT)
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Propel Mini", any status and sponsor, newest update first.
MedtronicPublic (MDT)
NCT06671561 · 0 participants · Start Jan 30, 2025 · Primary completion Aug 2026
Device: Observational data collection from patients with chronic rhinosinusitis (CRS) receiving PROPEL sinus implant(s) following functional endoscopic sinus surgery (FESS) · For: Chronic Rhinosinusitis (CRS)
Intersect ENTNot on our public-company list
NCT02880514 · 50 participants · Start Aug 2016 · Primary completion Dec 2016
Device: PROPEL Mini Sinus Implant · For: Chronic Sinusitis
Sites: Sacramento, California; Boca Raton, Florida; Atlanta, Georgia · 9 sites in all
- Safety and Efficacy of the Propel Mini and Propel Nova Steroid-Eluting Sinus Implant in Frontal SinusPivotal-lookingCompleted
Intersect ENTNot on our public-company list
NCT02266810 · 160 participants · Start Sep 2014 · Primary completion Apr 2016
Device: PROPEL Mini Sinus Implant.; Propel Nova Sinus Implant · For: Chronic Sinusitis
Sites: Sacramento, California; Torrance, California; Norwalk, Connecticut · 10 sites in all
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Propel Mini", and for the whole product code for context.
This brand
9 reports: 1 malfunction, 8 injury, 0 death
Whole product code OWO
36 reports: 7 malfunction, 29 injury, 0 death
Newest reports for this brand
3008301917-2024-00002 · Received Aug 30, 2024 · Event dated Mar 10, 2024
Device type: Drug-Eluting Sinus Stent (OWO)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Chemosis; Headache; Unspecified Infection; Impaired Healing; Sinusitis
3008301917-2024-00001 · Received Aug 26, 2024 · Event dated Mar 10, 2024
Device type: Drug-Eluting Sinus Stent (OWO)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Headache; Unspecified Infection; Impaired Healing; Sinusitis
3008301917-2020-00002 · Received Nov 14, 2020 · Event dated Oct 6, 2020
Device type: Drug-Eluting Sinus Stent (OWO)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Necrosis; Pain; Fungal Infection
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Propel Mini"[tiab]. The summary above synthesizes these.
- Evaluation of the PROPEL® mini sinus implant for the treatment of frontal sinus disease.
Santarelli GD, Han JK · Expert Opin Drug Deliv · 2016
- Adverse Events Associated With Corticosteroid-Eluting Sinus Stents: A MAUDE Database Analysis.
Narwani V, Torabi SJ, Kasle DA, et al. · Otolaryngol Head Neck Surg · 2022
- Use of Steroid-Eluting Stents after Endoscopic Repair of Choanal Atresia: A Case Series with Review.
Wilcox LJ, Smith MM, de Alarcon A, et al. · Ann Otol Rhinol Laryngol · 2020
- [The novel Propel mini stent - Indications, surgical technique and first clinical experience].
Weber CM, Schmidtmayer U, Stolle SRO, et al. · Laryngorhinootologie · 2019
- Treatment of choanal atresia in a cohort of 29 patients: Determinants for success or failure.
van Schaik CGR, Paasch S, Albrecht T, et al. · Int J Pediatr Otorhinolaryngol · 2022Observational Study
- Comparative Finite Element Evaluation of Polymeric and Metallic Bioresorbable Sinus Stents Under Quasi-Static Radial Compression.
Fu W, Yang A, Qiao A · J Funct Biomater · 2026
Other devices of this type
Also filed under product code OWO.
- PropelIntersect Ent. · PMA 2020
- Propel Contour Sinus ImplantIntersect Ent. · PMA 2017
- Intersect Ent Propel Mini Sinus ImplantIntersect Ent. · PMA 2014
- Intersectent Propel Mini Sinus ImplantIntersect Ent. · PMA 2013
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.